TRIB News and Press, Trinity Biotech plc From 09/27/23

DUBLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2023 on Tuesday, October 3, 2023. The ...

2023-09-12 06:56:57 ET Nasdaq has notified that Trinity Biotech ( NASDAQ: TRIB ) that the Company is not in compliance with Nasdaq listing rule, as the minimum bid price of the Company’s American depositary shares has been below US $1.00 per share for 30 consecutive busines...

DUBLIN, Ireland, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Premier Resolution System, an automated analyzer for the accurate & precise quantification of hemoglobins F and A2, and the detection of >200 hem...

2023-07-06 13:08:25 ET Gainers: EdtechX Holdings Acquisition ( EDTX ) +40% . Mullen Automotive ( MULN ) +35% . Genius Sports Limited ( GENI ) +21% . Incannex Healthcare Limited ( IXHL ) +19% . Sweetgreen ( SG ) +18% . urban-g...

2023-07-06 10:14:27 ET Trinity Biotech press release ( NASDAQ: TRIB ): Q1 GAAP ADS of -$0.152. Revenue of $14.83M (-5.4% Y/Y). For further details see: Trinity Biotech GAAP ADS of -$0.152, revenue of $14.83M

DUBLIN, Ireland, July 06, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended March 31, 2023. Summ...

2023-07-05 17:35:50 ET Trinity Biotech ( NASDAQ: TRIB ) is scheduled to announce Q1 earnings results on Thursday, July 6th, after market close. The consensus EPS Estimate is -$0.06 (+99.9% Y/Y) and the consensus Revenue Estimate is $18.5M (-1.5% Y/Y). Over the last 2 y...

DUBLIN, July 03, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2023 on Thursday, July 6, 2023. The Comp...

DUBLIN, Ireland, May 05, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today reported the receipt of a formal notification from The Nasd...

DUBLIN, Ireland, April 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that it has closed the recently announced sale ...